• News
  • Sport
  • TV
  • Radio
  • Education
  • TV Licences
  • Contact Us
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • FEATURES
  • OPINION
No Result
View All Result
1
Home Sci-tech

Moderna to seek regulatory approval for COVID-19 shot for very young children

23 March 2022, 9:01 PM  |
Reuters Reuters |  @SABCNews
Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021.

Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021.

Image: Reuters

Test tubes are seen in front of a displayed Moderna logo in this illustration taken, May 21, 2021.

Moderna Inc (MRNA.O) said on Wednesday it will ask regulators to authorise its COVID-19 vaccine in children younger than six years old based on data showing it generated a similar immune response to adults in its clinical trial.

The Omicron variant of COVID-19 was predominant during Moderna’s pediatric trial, and the drugmaker said two doses were around 38% effective in preventing infections in 2 to 5 year olds and 44% effective for children 6 months to under 2 years old.

It said these figures were consistent with the lower effectiveness against Omicron seen in adults who had received two doses of its vaccine.

Moderna’s vaccine could be the first authorised shot for children under the age of 5 in the United States, and many parents of young children have been waiting on a vaccine.

A rival shot made by Pfizer Inc (PFE.N) and Germany’s BioNTech SE (22UAy.DE) is authorized for use in children 5 and older. But their trial results for 2- to 4-year olds showed a weaker immune response than in adults, forcing the trial to be extended to test a third dose. Results are expected in April.

“Given the need for a vaccine against COVID-19 in infants and young children we are working with the U.S. FDA and regulators globally to submit these data as soon as possible,” Moderna Chief Executive Stephane Bancel said in a statement.

Dr. Jacqueline Miller, a top scientist at Moderna, told Reuters the company was “a couple of weeks away” from filing for authorization for the age group in the United States, Europe and elsewhere.

GENERALLY WELL-TOLERATED

It is not clear how many U.S. parents will vaccinate their children in the age group. Only 27% of 5-11 year olds in the country are fully vaccinated, and COVID-19 is generally more mild in children than adults.

There were no severe cases in Moderna’s pediatric trial for either vaccine or placebo partipicants.

Moderna said the shots, spaced four weeks apart, were generally well tolerated in the age group and the majority of side effects experienced were mild or moderate.

The dose size tested was 25 micrograms – a quarter of the dose that adults receive for each of their first two shots.

There have been some concerns about the size of the dose. By comparison, the dosage of Pfizer and BioNTech’s vaccine – which uses similar messenger RNA technology – was 10 micrograms for 5 to 11 year olds. They are testing 3 microgram doses for children younger than 5.

“FDA did ask us to evaluate lower doses and we intend to do so,” said Moderna’s Miller. “However, we believe that the current data really support the dose selections that we have made in this age group… We are confident in the dose that we’ve chosen.”

Moderna’s vaccine is approved by the FDA for use in adults 18 and older. But it has yet to be approved for 6 to 17 year olds in the United States despite gaining approval for that age group in Australia, Canada and the European Union. The United Kingdom and Switzerland have allowed the vaccine to be used in 12-17 year olds.

U.S. regulators have asked the company for more safety data and the FDA also said it needed additional time to evaluate the risk of a type of heart inflammation called myocarditis after vaccination in the age group, a rare side effect that has primarily affected young males.

Moderna says it plans to update its emergency use authorization filing in 12-17 year olds with more data, and has started the process for 6 to 11 year olds.

The company also said it plans to study a booster dose for all pediatric populations, including a booster that combines a vaccine designed to tackle the Omicron variant of the virus with its original COVID-19 vaccine.

Share article
Tags: COVID-19 vaccine
Previous Post

SA records 1 393 new COVID-19 cases

Next Post

SA’s Lerena to fight Romania’s Dinu on Saturday

Related Posts

A tap with a droplet of water.

UN Water Conference kicks off as world marks World Water Day

22 March 2023, 9:30 PM
Rahima Moosa Mother and Child Hospital, the Old Coronation Hospital.

“Report exposes state of Gauteng public health facilities”

15 March 2023, 11:09 AM
Members of Nehawu on strike

Phaahla links four deaths to Nehawu’s wage strike

9 March 2023, 1:00 PM
Silhouettes of mobile users are seen next to a screen projection of Instagram logo in this picture illustration taken March 28, 2018.

Instagram down for thousands of users globally

9 March 2023, 7:33 AM
[File Image]: A nurse at one of South Africa's hospital during the height of the coronavirus pandemic.

Patients suffer as health workers strike

9 March 2023, 7:30 AM
A representation of depression

Negative impact of rolling blackouts on mental health

7 March 2023, 5:56 PM
Next Post
Boxing gloves.

SA's Lerena to fight Romania's Dinu on Saturday

Most Viewed

  • 24hrs
  • Week
  • Month
  • Deadline for Zimbabwean Exemption Permits draws near
  • Durban’s N2 road, Spaghetti Junction closed due to cleanup operations
  • DENOSA defends nurses for placing newborns in boxes
  • Limpopo teacher writes a book which simplifies Maths
  • Limpopo healthcare set to get massive boost with multi-billion rand hospital
  • Dr Nandipha’s looks during court appearances under the spotlight
  • Experts raise caution over Prime energy drink craze
  • Reserve Bank expected to increase repo rate on Thursday
  • Deadline for Zimbabwean Exemption Permits draws near
  • Zimbabwe receives 18 helicopters from Russian Federation
  • Mabuyane taking President, SIU and University of Fort Hare to court
  • Speaker dismissed me when I requested a meeting: Mkhwebane
  • SIU to defend Mabuyane’s application in Fort Hare matter: Kganyago
  • Magudumana was in Tanzania illegally, argues police representative in court
  • Work being done provides solid hope that electricity crisis will end: Ramaphosa

LATEST

Members of the Ugandan army, part of the troops to the East Africa Community Regional Force (EACRF), patrol a settlement ceded by M23 rebels fighters to EACRF soldiers in Bunagana, Rutshuru territory of the North Kivu province of DRC, April 19, 2023
  • Africa

Warring DRC parties called to lay down their weapons


Netball World Cup trophy on display
  • Sport

Netball World Cup trophy tour invokes special feeling among locals


  • South Africa

VIDEO | Minister Pandor briefs media on BRICS Foreign Affairs Ministers meeting


A classroom with desks and chairs.
  • South Africa

Teaching, learning halted at Estralita Special School, Nehawu alleges nepotism


Sudanese soldiers secure the area as Sudan's ex-president Omar al-Bashir leaves the office of the anti-corruption prosecutor.
  • Africa

UN rejects request to replace Special Representative to Sudan


Alfred Nzo District Municipality Mayor Vukile Mhlelembana at the Anti-Corruption and Ethics Workshop on 05 May 2023.
  • South Africa

Alfred Nzo District Municipality adopts R1.6 billion budget


Weather

  • About the SABC
  • Contact Us
  • Jobs
  • Advertise
  • Disclaimer
  • Site Map

SABC © 2023

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • FEATURES
  • OPINION

© 2023

Previous SA records 1 393 new COVID-19 cases
Next SA’s Lerena to fight Romania’s Dinu on Saturday